CD4 and COVID-19: Interestingly, recovery from COVID‐19 does not appear to substantially increase the abundance of iCope‐reactive CD4+ T cells (Figure 2C), yet these cells have been shown to be engaged early during infection and vaccination with beneficial effects [18].